1147-B Encapsulation of IL-12 with an ultra pH-sensitive tumor delivery platform improves tolerability and promotes antitumor response in a preclinical model

• Tian Zhao,
• Qingtai Su,
• Stephen Gutowski,
• Austin Burcham,
• Irina Kalashnikova,
• Zirong Chen,
• Bhargavi Allu,
• Ruolan Han,
• Kartik Krishnan,
• Jason B Miller

Affiliations

Tian Zhao

3OncoNano Medicine Inc., Allen, TX, USA

Qingtai Su

1OncoNano Medicine, Inc., Southlake, TX, USA

Stephen Gutowski

1OncoNano Medicine, Inc., Southlake, TX, USA

Austin Burcham

1OncoNano Medicine, Inc., Southlake, TX, USA

Irina Kalashnikova

1OncoNano Medicine, Inc., Southlake, TX, USA

Zirong Chen

2OncoNano Medicine, Prosper, TX, USA

Bhargavi Allu

1OncoNano Medicine, Inc., Southlake, TX, USA

Ruolan Han

1OncoNano Medicine, Inc., Southlake, TX, USA

Kartik Krishnan

1OncoNano Medicine, Inc., Southlake, TX, USA

Jason B Miller

1OncoNano Medicine, Inc., Southlake, TX, USA